Ulcerative Colitis Clinical Trials

Showing 5861-5880 of 7,290 trials

Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia

NCT02731378

A multicentre, randomized, open-label, parallel-group, active controlled non-inferiority study

Shanghai East Hospital603 participantsStarted Dec 2016

Shanghai, Shanghai Municipality, China • Shanghai, Shanghai Municipality, China • Shanghai, Shanghai Municipality, China +3 more locations

COMPLETEDNA

Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss

NCT02951715

Twenty patients with tinnitus and a typical noise-induced hearing loss (NIHL) audiogram were included. Each subject underwent an otoscopic examination, distortion product otoacoustic emissions, tinnitus-match testing, Tinnitus Handicap Inventory (THI) and serum zinc level analyses. After 2 months of treatment with zinc, all tests were repeated.

Hearing Loss, Noise-InducedTinnitus, Noise InducedZinc Deficiency

Chang Gung Memorial Hospital20 participantsStarted Dec 2013

UNKNOWNNA

Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD

NCT02790047

The aim of this study to investigate the efficacy of a home-base exercise program with a new conical PEP device on physical performance and health related quality of life in COPD patients.

Chronic Obstructive Pulmonary Disease

Khon Kaen University50 participantsStarted Oct 2016

Khon Kaen, Changwat Khon Kaen, Thailand • Khon Kaen, Changwat Khon Kaen, Thailand

Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia

Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss

Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD

Related Searches

Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG

ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Thrombocytopathy in Gaucher Disease Patients

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients

ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.

A Randomised Controlled Trial of Lumbar Drainage to Treat Communicating Hydrocephalus After Severe Intraventricular Hemorrhage

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects

Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients

Understanding Hallucinations (Part I)

Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life

Tracking Optical Coherence Tomography

Conventional Follow-up Versus Mobile App For Post-Operative ACL Reconstruction Patients

Validation of the 1-minute Sit-to-stand Test in Patients With COPD

Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi

CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM